Verana Health Expands IRIS Registry with Ophthalmic Imaging Consortium
Event summary
- Verana Health launched an Imaging Consortium with Academic Medical Centers to integrate ophthalmic images into its IRIS Registry Analytics Consortium.
- The expansion adds Optical Coherence Tomography (OCT) and fundus photography to the existing 12+ years of longitudinal data on 87 million de-identified patients.
- AI will be used to analyze images and unstructured EHR notes for standardized datasets to support drug development and clinical trials.
- Verana Health will host a webinar on March 26, 2026, to discuss AI's role in retinal image analysis.
The big picture
Verana Health's Imaging Consortium expansion positions it as a leader in real-world ophthalmology data, combining AI with high-quality imaging to enhance disease management. This move aligns with broader industry trends toward leveraging AI for medical imaging analysis, potentially setting a new standard for ophthalmic research and clinical decision-making.
What we're watching
- Data Utilization
- How the integration of imaging data will accelerate disease detection and monitoring for conditions like diabetic retinopathy and glaucoma.
- AI Adoption
- Whether AI-driven analysis of ophthalmic images can deliver scalable insights for drug development and clinical trials.
- Market Differentiation
- The pace at which Verana Health can leverage this expanded dataset to outpace competitors in ophthalmology research.